Isolation for Herpes Zoster Infection
For immunocompetent patients with localized herpes zoster, cover all lesions completely and restrict from caring for high-risk patients (immunocompromised, pregnant women, neonates, varicella-naive individuals) until all lesions are dry and crusted; for disseminated zoster or any zoster in immunocompromised patients, implement both airborne and contact precautions with negative air-flow rooms until all lesions are dry and crusted. 1
Isolation Requirements by Clinical Presentation
Localized Herpes Zoster in Immunocompetent Patients
- Standard and contact precautions with complete lesion coverage are sufficient 2, 3
- Maintain at least 6 feet physical separation from other patients 3
- Patient should wear a surgical mask to prevent droplet transmission 3
- Restrict from caring for high-risk patients including immunocompromised persons, pregnant women, neonates, and varicella-naive individuals until all lesions are dry and crusted 1
- Airborne precautions are NOT required for localized disease in immunocompetent hosts 3
Disseminated Herpes Zoster (Any Immune Status)
- Both airborne AND contact precautions are mandatory regardless of immune status 1, 2, 3
- Negative air-flow rooms are required 1, 3
- If negative air-flow rooms are unavailable, isolate in closed rooms with no contact permitted for persons lacking varicella immunity 1
- Exclude healthcare personnel from duty entirely until all lesions are dry and crusted 1
Any Herpes Zoster in Immunocompromised Patients
- Implement both airborne and contact precautions until disseminated infection is ruled out 1, 3
- Negative air-flow room required 3
- Exclude from duty if healthcare personnel; if patient, only immune healthcare workers may provide care 1
- These patients experience prolonged viral shedding (7-14 days or longer vs. 4-7 days in immunocompetent) 2, 3
Duration of Isolation
Standard Timeline
- Contagiousness begins 1-2 days before rash onset 2
- Continue isolation until all lesions are dry and crusted, typically 4-7 days after rash onset 1, 2, 4
- For non-crusting lesions (macules and papules only), isolation ends when no new lesions appear within a 24-hour period 1, 2
Extended Timeline for Immunocompromised
- Healing may take 7-14 days or longer 2, 3
- Progressive varicella (new lesions >7 days) indicates depressed immune response and extends contagious period 2
- Maintain precautions until complete crusting regardless of duration 3
Healthcare Personnel Management
Personnel with Localized Zoster
- Cover all lesions completely 1
- Restrict from high-risk patient care until lesions crust 1, 2
- May continue other duties with proper lesion coverage 1
Personnel with Disseminated Zoster or Immunocompromised Status
- Exclude from duty entirely until all lesions dry and crust 1
Postexposure Management of Susceptible Personnel
- Exposure defined as close indoor contact (same room) or face-to-face contact, not transitory contact 1
- Personnel with 2 doses of varicella vaccine: monitor days 8-21 for fever, lesions, systemic symptoms; exclude immediately if symptoms develop 1
- Personnel with 1 dose: give second dose within 3-5 days of exposure; if not given, exclude days 8-21 1
- Unvaccinated personnel without immunity: furlough days 8-21 after exposure (or days 8-28 if varicella-zoster immune globulin administered) 1
High-Risk Populations Requiring Protection
Individuals Who Must Avoid Exposure
- Pregnant women (maternal zoster does not cause congenital syndrome but increases maternal morbidity) 2, 5
- Neonates and premature infants (especially if mother developed varicella 5 days before to 2 days after delivery, with 17-30% severe infection risk and historical 31% mortality) 2
- Immunocompromised persons at increased risk for severe disease 1, 2
- Varicella-naive individuals without history of chickenpox or vaccination 2
Transmission Characteristics
Transmission Routes
- Direct contact with vesicle fluid is the primary route 2, 3
- Airborne transmission is possible but primarily documented in healthcare settings 2, 3
- Herpes zoster is approximately 20% as contagious as varicella 2, 3
- Cannot transmit shingles directly—only VZV causing chickenpox in susceptible individuals 2
Environmental Considerations
- Environmental surfaces in patient rooms can be extensively contaminated with VZV 3
- Dedicate noncritical items to isolated patients and adequately clean/disinfect before use on other patients 3
Treatment Considerations Affecting Isolation
Antiviral Therapy Impact
- Antiviral therapy (valacyclovir 1 gram 3 times daily for 7 days, or famciclovir, or acyclovir) reduces time to lesion healing 6, 4, 7
- Starting antivirals does NOT immediately render patient non-contagious—viral shedding continues until lesions fully crust 2, 3
- Therapy most effective when started within 48-72 hours of rash onset 6, 4, 8
- Immunocompromised patients may require higher doses or longer courses 2, 7
Immunomodulator Therapy
- Do not start immunomodulator therapy during active shingles 2
- Can only reintroduce after all vesicles have crusted over and fever has resolved 2
Critical Pitfalls to Avoid
- Never assume antiviral therapy makes patient immediately non-contagious—viral shedding continues until complete crusting 2, 3
- Never allow healthcare workers to care for high-risk patients before complete crusting, even with covered lesions 1, 2
- Never assume localized disease in immunocompromised patients—rule out disseminated infection before downgrading precautions 3
- Never use standard precautions alone for disseminated disease—both airborne and contact precautions required simultaneously 3
- Never allow healthcare personnel without documented varicella immunity to provide care, even briefly 3
- Never inadequately cover lesions in localized disease, as this can lead to transmission 2